All Roll Calls
Yes: 175 • No: 1
Sponsored By: Matthew S. Dawson (Democratic)
Signed by Governor
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
4 provisions identified: 0 benefits, 1 costs, 3 mixed.
The state repeals its prior intractable pain treatment laws (Ch. 5‑37.4 and Ch. 5‑37.5). Patients and providers no longer rely on the special rights or procedures in those chapters. Care now follows the updated Uniform Controlled Substances Act and health department rules.
The law sets safer opioid prescribing rules. For adults, a first prescription for acute pain is limited to 7 days. For patients under 18, any opioid prescription is capped at 20 doses unless the doctor documents a medical need. Before prescribing, the doctor must discuss risks and non‑opioid options, record that talk, and offer naloxone. Prescribers must check the state drug‑monitoring system before starting or refilling, and at least every 3 months for patients on opioids 3 months or more, and document the check. The law removes fixed dose numbers and relies on professional standards and clinical judgment. The health department can publish best‑practice advice and rules, including when to co‑prescribe naloxone and how to spot high overdose risk.
Starting January 1, 2023, opioid medications mean FDA‑approved opioid drugs and include partial agonists like buprenorphine. The law defines acute pain (generally under 30 days) and chronic pain (90 days or more). “Chronic intractable pain” must be severe, constant, and supported by a written diagnosis from a Rhode Island‑licensed pain specialist, oncologist, or similar specialist. The statute also replaces “opiate” with “opioid” in the narcotic drug definition as of January 1, 2023. It repeals the old definitions section and updates many terms, like practitioner, therapeutic purpose, and ultimate user, to guide how the law is applied.
The act takes effect upon passage.
Matthew S. Dawson
Democratic • House
There are no cosponsors for this bill.
All Roll Calls
Yes: 175 • No: 1
House vote • 6/11/2026
UNIFORM CONTROLLED SUBSTANCES AC PASSAGE IN CONCURRENCE
Yes: 68 • No: 0
Senate vote • 6/11/2026
RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCE ACT Passage
Yes: 37 • No: 1
House vote • 3/26/2026
UNIFORM CONTROLLED SUB. ACT PASSAGE
Yes: 70 • No: 0
Signed by Governor — Chapter 314
Transmitted to Governor
House passed Sub A in concurrence
Placed on House Calendar (06/11/2026)
Senate read and passed
Placed on Senate Calendar (06/11/2026)
Committee recommends passage of Sub A
Proposed Substitute
Scheduled for consideration (06/09/2026)
Referred to Senate Health and Human Services
House read and passed
Placed on House Calendar (03/26/2026)
Committee recommends passage
Scheduled for consideration (03/19/2026)
Committee recommended measure be held for further study
Scheduled for hearing and/or consideration (03/03/2026)
Introduced, referred to House Health & Human Services
H7923 - As Introduced
2/27/2026
H7923 - Substitute
2/27/2026
H8104, AN ACT RELATING TO PROPERTY -- MORTGAGES OF REAL PROPERTY .
H8046, AN ACT RELATING TO COURTS AND CIVIL PROCEDURE--PROCEDURE GENERALLY -- FEES .
H8025, AN ACT RELATING TO TAXATION -- PROPERTY SUBJECT TO TAXATION .
H7866, AN ACT RELATING TO INSURANCE -- UNFAIR CLAIMS SETTLEMENT PRACTICES ACT .
H7642, AN ACT RELATING TO COURTS AND CIVIL PROCEDURE -- PROCEDURE GENERALLY -- DISTRICT COURT PRACTICE .
S3363, AN ACT RELATING TO TAXATION -- PROPERTY SUBJECT TO TAXATION .